Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana Brockbals

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Analytical and Bioanalytical Chemistry|November 24, 2019
Analytical considerations for postmortem metabolomics using GC-high-resolution MSLana Brockbals, Thomas Kraemer, Andrea E Steuer
Frontiers in Chemistry|May 29, 2019
Metabolomic Strategies in Biomarker Research-New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?Andrea E Steuer, Lana Brockbals, Thomas Kraemer
Journal of Analytical Toxicology|June 16, 2026
Performance Evaluation of a Commercial LC-HRMS Platform for Untargeted Whole Blood Analysis: Comparison with Immunoassay and LRMS Urine Screening and Targeted LC-MS/MS (MRM) Whole Blood QuantificationAnnina Bovens, Lana Brockbals, Thomas Kraemer, et al.
Talanta|December 31, 2024
Development and thorough evaluation of a multi-omics sample preparation workflow for comprehensive LC-MS/MS-based metabolomics, lipidomics and proteomics datasetsLana Brockbals, Maiken Ueland, Shanlin Fu, et al.
Metabolites|December 24, 2025
Assessing the Feasibility of In Vitro Assays in Combination with Biological Matrices to Screen for Endogenous CYP450 Phenotype Biomarkers Using an Untargeted Metabolomics Approach-A Proof of Concept StudyYannick Wartmann, Lana Brockbals, Thomas Kraemer, et al.
Drug Testing and Analysis|May 7, 2020
Postmortem metabolomics: Correlating time-dependent concentration changes of xenobiotic and endogenous compoundsLana Brockbals, Sandra N Staeheli, Thomas Kraemer, et al.
International Journal of Legal Medicine|December 25, 2025
Peptide ratios for post-mortem interval estimation using targeted liquid chromatography triple quadrupole mass spectrometryJenna Ireland, Lana Brockbals, Dennis McNevin, et al.
Drug Testing and Analysis|February 25, 2023
Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimationLana Brockbals, Andreas Thomas, Tom D Schneider, et al.
Drug Testing and Analysis|February 12, 2025
Evaluation of Bladder Wash as an Alternative Specimen for Postmortem Toxicology: Comparison to Screening Results of Urine and Kidney TissueAndrea E Steuer, Lana Brockbals, Sandra N Poetzsch, et al.
Analytical and Bioanalytical Chemistry|July 9, 2023
Estimating the time of human decomposition based on skeletal muscle biopsy samples utilizing an untargeted LC-MS/MS-based proteomics approachLana Brockbals, Samara Garrett-Rickman, Shanlin Fu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Analytical and Bioanalytical Chemistry|November 24, 2019
Analytical considerations for postmortem metabolomics using GC-high-resolution MSLana Brockbals, Thomas Kraemer, Andrea E Steuer
Frontiers in Chemistry|May 29, 2019
Metabolomic Strategies in Biomarker Research-New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?Andrea E Steuer, Lana Brockbals, Thomas Kraemer
Journal of Analytical Toxicology|June 16, 2026
Performance Evaluation of a Commercial LC-HRMS Platform for Untargeted Whole Blood Analysis: Comparison with Immunoassay and LRMS Urine Screening and Targeted LC-MS/MS (MRM) Whole Blood QuantificationAnnina Bovens, Lana Brockbals, Thomas Kraemer, et al.
Talanta|December 31, 2024
Development and thorough evaluation of a multi-omics sample preparation workflow for comprehensive LC-MS/MS-based metabolomics, lipidomics and proteomics datasetsLana Brockbals, Maiken Ueland, Shanlin Fu, et al.
Metabolites|December 24, 2025
Assessing the Feasibility of In Vitro Assays in Combination with Biological Matrices to Screen for Endogenous CYP450 Phenotype Biomarkers Using an Untargeted Metabolomics Approach-A Proof of Concept StudyYannick Wartmann, Lana Brockbals, Thomas Kraemer, et al.
Drug Testing and Analysis|May 7, 2020
Postmortem metabolomics: Correlating time-dependent concentration changes of xenobiotic and endogenous compoundsLana Brockbals, Sandra N Staeheli, Thomas Kraemer, et al.
International Journal of Legal Medicine|December 25, 2025
Peptide ratios for post-mortem interval estimation using targeted liquid chromatography triple quadrupole mass spectrometryJenna Ireland, Lana Brockbals, Dennis McNevin, et al.
Drug Testing and Analysis|February 25, 2023
Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimationLana Brockbals, Andreas Thomas, Tom D Schneider, et al.
Drug Testing and Analysis|February 12, 2025
Evaluation of Bladder Wash as an Alternative Specimen for Postmortem Toxicology: Comparison to Screening Results of Urine and Kidney TissueAndrea E Steuer, Lana Brockbals, Sandra N Poetzsch, et al.
Analytical and Bioanalytical Chemistry|July 9, 2023
Estimating the time of human decomposition based on skeletal muscle biopsy samples utilizing an untargeted LC-MS/MS-based proteomics approachLana Brockbals, Samara Garrett-Rickman, Shanlin Fu, et al.
Pageof 2